Center Hospitalier Universitaire, Angers, France has ordered a PrepLog® system. The system will be used for final control of cytotoxic drugs at the hospital pharmacy and will be integrated with the hospital’s prescribing system. The agreement is entered into with Pharmacolog France SARL.
Center Hospitalier Universitaire, Angers (CHU) was founded in 1175 and is one of the oldest hospitals in France with 1350 beds and an extensive oncology operation. CHU has for a number of years used a competing system for final control of cytotoxic preparations compounded at the hospital pharmacy. CHU has now signed an agreement with Pharmacolog France SARL to install the new PrepLog® system that enables integration with their prescription software Chimio, from the company Computer Engineering. The integrated solution means improved workflow and automated reporting functions. The agreement involves a turnover in the French subsidiary of just over SEK 600,000 over the first two years.
CEO Mats Högberg comments: “We are very pleased that CHU in Angers chooses to replace its current quality control system with PrepLog®. CHU has an extensive oncology operation and prepares around 30,000 cytotoxic treatments annually. We also see it as an important proof of our product’s competitiveness as CHU, with this order, chooses to switch from its current solution to PrepLog®. As they switch to PrepLog®, CHU will significantly streamline quality work as PrepLog® allows for a fully integrated workflow and complete traceability of test results that were not previously possible.”
For more information contact:
Mats Högberg, CEO
Email: mats.hogberg@pharmacolog.com
Phone: +46 70-546 50 21
This information is insider information that Pharmacolog AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication through the agency of the contact person set out above, on 2021-02-08, at 10:15.
About Pharmacolog AB
Pharmacolog is specialized in developing systems and solutions for more effective and safer use of intravenous drugs. The company’s first product, DrugLog®, enables a nurse or pharmacist to quickly and easily verify that an injectable drug has the right identity and concentration. Pharmacolog’s long-term vision is an individually optimized medication for each individual patient, considering all available parameters in the control and distribution of the drug. Further information regarding the company is available at http://www.pharmacolog.com. The company’s Certified Adviser is Mangold Fondkommission AB, which can be reached on telephone number +46 8-5030 15 50 or through CA@mangold.se.
Release